Key result
A quality improvement initiative reduced monthly spending on sugammadex by 52% ($70,777 vs $33,821) while increasing medication access via automated dispensers.
Why the study?
High costs limit the widespread use of sugammadex compared to neostigmine, making it vital to reduce unnecessary spending while ensuring timely perioperative access.
Answers are grounded in this paper and cite their sources.
A quality improvement initiative successfully reduced sugammadex spending by 52% while improving access through automated dispensers.
The relatively high cost of sugammadex compared to neostigmine limits its widespread use to reverse neuromuscular blockade, despite its faster onset and more complete clinical effect. While ensuring timely access to sugammadex is important in improving perioperative safety, it is also vital to control unnecessary spending. We describe a quality improvement initiative to reduce excess spending on sugammadex while improving access for anesthesia providers. Monthly spending on sugammadex decreased by 52% ($70,777 vs $33,821), while medication access increased via automated medication dispensers in each operating room. Clinical usage decreased by one-third, with presumed increased adherence to dosing guidelines.
No takes yet. Share an insight, caveat, or question.
Pimentel et al. (2020) studied Neuromuscular blockade reversal. Quality improvement initiative (medication stewardship and automated dispensers) vs. Pre-initiative was evaluated on Monthly spending on sugammadex (52% decrease). A quality improvement initiative reduced monthly spending on sugammadex by 52% ($70,777 vs $33,821) while increasing medication access via automated dispensers.
Synapse has enriched 10 related papers. Consider them for comparative context: